Literature DB >> 21603989

Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Domenico Genovesi1, Giampiero Ausili Cèfaro, Annamaria Vinciguerra, Antonietta Augurio, Monica Di Tommaso, Rita Marchese, Umberto Ricardi, Andrea Riccardo Filippi, Theodore Girinsky, Katiuscia Di Biagio, Maurizio Belfiglio, Enza Barbieri, Vincenzo Valentini.   

Abstract

BACKGROUND: To determine interobserver variability in clinical target volume (CTV) of supra-diaphragmatic Hodgkin's lymphoma.
MATERIALS AND METHODS: At the 2008 AIRO (Italian Society of Radiation Oncology) Meeting, the Radiation Oncology Department of Chieti proposed a multi-institutional contouring dummy-run of two cases of early stage supra-diaphragmatic Hodgkin's lymphoma after chemotherapy. Clinical history, diagnostics, and planning CT imaging were available on Chieti's radiotherapy website (www.radioterapia.unich.it). Participating centers were requested to delineate the CTV and submit it to the coordinating center. To quantify interobserver variability of CTV delineations, the total volume, craniocaudal, laterolateral, and anteroposterior diameters were calculated.
RESULTS: A total of 18 institutions for case A and 15 institutions for case B submitted the targets. Case A presented significant variability in total volume (range: 74.1-1,157.1 cc), craniocaudal (range: 6.5-22.5 cm; median: 16.25 cm), anteroposterior (range: 5.04-14.82 cm; median: 10.28 cm), and laterolateral diameters (range: 8.23-22.88 cm; median: 15.5 cm). Mean CTV was 464.8 cc (standard deviation: 280.5 cc). Case B presented significant variability in total volume (range: 341.8-1,662 cc), cranio-caudal (range: 8.0-28.5 cm; median: 23 cm), anteroposterior (range: 7.9-1.8 cm; median: 11.1 cm), and laterolateral diameters (range: 12.9-24.0 cm; median: 18.8 cm). Mean CTV was 926.0 cc (standard deviation: 445.7 cc).
CONCLUSION: This significant variability confirms the need to apply specific guidelines to improve contouring uniformity in Hodgkin's lymphoma.

Entities:  

Mesh:

Year:  2011        PMID: 21603989     DOI: 10.1007/s00066-011-2221-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  41 in total

1.  Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of the clinical target volume. A comparison between gynaecologic and radiation oncologists.

Authors:  Elisabeth Weiss; Susanne Richter; Thomas Krauss; Silke I Metzelthin; Andrea Hille; Olivier Pradier; Birgit Siekmeyer; Hilke Vorwerk; Clemens F Hess
Journal:  Radiother Oncol       Date:  2003-04       Impact factor: 6.280

2.  Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.

Authors:  Evert M Noordijk; Patrice Carde; Noëlle Dupouy; Anton Hagenbeek; Augustinus D G Krol; Johanna C Kluin-Nelemans; Umberto Tirelli; Mathieu Monconduit; José Thomas; Houchingue Eghbali; Berthe M P Aleman; Jacques Bosq; Marjeta Vovk; Tom A M Verschueren; Anne-Marie Pény; Théodore Girinsky; John M M Raemaekers; Michel Henry-Amar
Journal:  J Clin Oncol       Date:  2006-06-05       Impact factor: 44.544

3.  Sample size planning for the coefficient of variation from the accuracy in parameter estimation approach.

Authors:  Ken Kelley
Journal:  Behav Res Methods       Date:  2007-11

4.  Irradiation of paranasal sinus tumors, a delineation and dose comparison study.

Authors:  Coen Rasch; Avraham Eisbruch; Peter Remeijer; Luc Bos; Mischa Hoogeman; Marcel van Herk; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-01-01       Impact factor: 7.038

5.  Interobserver variability and accuracy of computed tomographic assessment of nodal status in lung cancer.

Authors:  E C Bollen; R Goei; B E van 't Hof-Grootenboer; C W Versteege; H A Engelshove; R J Lamers
Journal:  Ann Thorac Surg       Date:  1994-07       Impact factor: 4.330

6.  Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials.

Authors:  Olav Favier; Natacha Heutte; Aspasia Stamatoullas-Bastard; Patrice Carde; Mars B Van't Veer; Berthe M P Aleman; Evert M Noordijk; José Thomas; Christophe Fermé; Michel Henry-Amar
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

7.  Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.

Authors:  Bhishamjit S Chera; Christina Rodriguez; Christopher G Morris; Debbie Louis; Daniel Yeung; Zuofeng Li; Nancy P Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-20       Impact factor: 7.038

8.  Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.

Authors:  Theodoros P Vassilakopoulos; Maria K Angelopoulou; Marina P Siakantaris; Flora N Kontopidou; Maria N Dimopoulou; Styliani I Kokoris; Marie Christine Kyrtsonis; Panayiotis Tsaftaridis; Christos Karkantaris; Konstantinos Anargyrou; Dimitrios E Boutsis; Eleni Variamis; Thymios Michalopoulos; Vassiliki A Boussiotis; Panayiotis Panayiotidis; Constantinos Papavassiliou; Gerassimos A Pangalis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-01       Impact factor: 7.038

9.  Interobserver variation in the computed tomographic evaluation of mediastinal lymph node size in patients with potentially resectable lung cancer. Canadian Lung Oncology Group.

Authors:  G H Guyatt; M Lefcoe; S Walter; D Cook; S Troyan; L Griffith; D King; C Zylak; N Hickey; G Carrier
Journal:  Chest       Date:  1995-01       Impact factor: 9.410

10.  Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.

Authors:  Belinda A Campbell; Nick Voss; Tom Pickles; James Morris; Randy D Gascoyne; Kerry J Savage; Joseph M Connors
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

View more
  11 in total

1.  Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.

Authors:  I Fotina; C Lütgendorf-Caucig; M Stock; R Pötter; D Georg
Journal:  Strahlenther Onkol       Date:  2012-01-27       Impact factor: 3.621

2.  Assessment of accuracy and efficiency of atlas-based autosegmentation for prostate radiotherapy in a variety of clinical conditions.

Authors:  I Simmat; P Georg; D Georg; W Birkfellner; G Goldner; M Stock
Journal:  Strahlenther Onkol       Date:  2012-06-07       Impact factor: 3.621

3.  Delineation of the larynx as organ at risk in radiotherapy: a contouring course within "Rete Oncologica Piemonte-Valle d'Aosta" network to reduce inter- and intraobserver variability.

Authors:  Domenico Cante; Edoardo Petrucci; Cristina Piva; Valeria Casanova Borca; Piera Sciacero; Maurizio Bertodatto; Caterina Marta; Pierfrancesco Franco; Monica Viale; Giovanni La Valle; Maria Rosa La Porta; Oscar Bertetto
Journal:  Radiol Med       Date:  2016-07-15       Impact factor: 3.469

4.  Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin's lymphoma. A case study.

Authors:  C Lütgendorf-Caucig; I Fotina; E Gallop-Evans; L Claude; J Lindh; T Pelz; B Knäusl; D Georg; R Pötter; K Dieckmann
Journal:  Strahlenther Onkol       Date:  2012-10-10       Impact factor: 3.621

5.  Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.

Authors:  Marianna Trignani; Angela Argenone; Saide Di Biase; Daniela Musio; Anna Merlotti; Stefano Ursino; Ester Orlandi; Domenico Genovesi; Almalina Bacigalupo
Journal:  Radiol Med       Date:  2019-03-09       Impact factor: 3.469

6.  Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma : Results of Korean Radiation Oncology Group 1207 study.

Authors:  Young Suk Kim; Jun Won Kim; Won Sup Yoon; Min Kyu Kang; Ik Jae Lee; Tae Hyun Kim; Jin Hee Kim; Hyung-Sik Lee; Hee Chul Park; Hong Seok Jang; Chul Seung Kay; Sang Min Yoon; Mi-Sook Kim; Jinsil Seong
Journal:  Strahlenther Onkol       Date:  2016-08-18       Impact factor: 3.621

7.  Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors.

Authors:  C G Vos; M Dahele; J R van Sörnsen de Koste; S Senan; I Bahce; M A Paul; E Thunnissen; E F Smit; K J Hartemink
Journal:  Strahlenther Onkol       Date:  2013-12-22       Impact factor: 3.621

8.  Automatic image segmentation based on synthetic tissue model for delineating organs at risk in spinal metastasis treatment planning.

Authors:  Olaf Wittenstein; Patrick Hiepe; Lars Henrik Sowa; Elias Karsten; Iris Fandrich; Juergen Dunst
Journal:  Strahlenther Onkol       Date:  2019-04-29       Impact factor: 3.621

9.  Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.

Authors:  Luciana Caravatta; Gabriella Macchia; Gian Carlo Mattiucci; Aldo Sainato; Nunzia L V Cernusco; Giovanna Mantello; Monica Di Tommaso; Marianna Trignani; Antonino De Paoli; Gianni Boz; Maria L Friso; Vincenzo Fusco; Marta Di Nicola; Alessio G Morganti; Domenico Genovesi
Journal:  Radiat Oncol       Date:  2014-09-08       Impact factor: 3.481

10.  Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?

Authors:  Barbara Segedin; Primoz Petric
Journal:  Radiol Oncol       Date:  2016-05-09       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.